CO5170493A1 - Articulos de fabricacion - Google Patents
Articulos de fabricacionInfo
- Publication number
- CO5170493A1 CO5170493A1 CO00029997A CO00029997A CO5170493A1 CO 5170493 A1 CO5170493 A1 CO 5170493A1 CO 00029997 A CO00029997 A CO 00029997A CO 00029997 A CO00029997 A CO 00029997A CO 5170493 A1 CO5170493 A1 CO 5170493A1
- Authority
- CO
- Colombia
- Prior art keywords
- inhibition
- phosphodiesterase
- pde5
- pde
- inhibitors
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 102000011016 Type 5 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 3
- 108010037581 Type 5 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 3
- 230000005764 inhibitory process Effects 0.000 abstract 3
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 101100296726 Caenorhabditis elegans pde-5 gene Proteins 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Formation And Processing Of Food Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Glass Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13203699P | 1999-04-30 | 1999-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5170493A1 true CO5170493A1 (es) | 2002-06-27 |
Family
ID=22452153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00029997A CO5170493A1 (es) | 1999-04-30 | 2000-04-26 | Articulos de fabricacion |
Country Status (47)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1200091B1 (en) * | 1999-08-03 | 2008-07-02 | Lilly Icos LLC | Pharmaceutical composition comprising tadalafil |
| DE10010612A1 (de) * | 2000-03-03 | 2001-09-27 | Merck Patent Gmbh | Verwendung von PDE V-Inhibitoren |
| EP1289990A1 (en) * | 2000-06-08 | 2003-03-12 | Lilly Icos LLC | Tetracyclic diketopierazine compounds as pdev inhibitors |
| US7034027B2 (en) | 2000-08-02 | 2006-04-25 | Lilly Icos Llc | Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| DE60219788T2 (de) * | 2001-06-05 | 2008-01-17 | Lilly Icos Llc, Wilmington | Tetrazyklische verbindungen als pde5-inhibitoren |
| GB0129274D0 (en) * | 2001-12-06 | 2002-01-23 | Pfizer Ltd | Novel kit |
| US20060205733A1 (en) * | 2004-08-26 | 2006-09-14 | Encysive Pharmaceuticals | Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
| EP2004203A4 (en) * | 2006-03-28 | 2010-03-31 | Javelin Pharmaceuticals Inc | FORMULATIONS OF DICLOFENAC AND CYCLODEXTRIN BETA WITH LOW DOSAGE |
| US7495024B2 (en) | 2006-08-07 | 2009-02-24 | Via Pharmaceuticals, Inc. | Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque |
| DE102007028869A1 (de) | 2007-06-22 | 2008-12-24 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil |
| DE102009033396A1 (de) | 2009-07-16 | 2011-01-20 | Ratiopharm Gmbh | Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung |
| US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
| US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
| US20110263606A1 (en) * | 2010-04-26 | 2011-10-27 | Horst Zerbe | Solid oral dosage forms comprising tadalafil |
| WO2012107541A1 (en) | 2011-02-10 | 2012-08-16 | Synthon Bv | Pharmaceutical composition comprising tadalafil and a cyclodextrin |
| WO2012107090A1 (en) | 2011-02-10 | 2012-08-16 | Synthon Bv | Granulated composition comprising tadalafil and a disintegrant |
| WO2012107092A1 (en) | 2011-02-10 | 2012-08-16 | Synthon Bv | Pharmaceutical composition comprising tadalafil and a cyclodextrin |
| KR102239291B1 (ko) | 2013-06-28 | 2021-04-14 | 한미약품 주식회사 | 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제 |
| KR20150056443A (ko) | 2013-11-15 | 2015-05-26 | 한미약품 주식회사 | 타다라필 및 암로디핀을 포함하는 복합제제 |
| KR102646431B1 (ko) | 2017-09-29 | 2024-03-12 | 한미약품 주식회사 | 생산성 및 균일성이 개선된 타다라필을 함유하는 고형제제 및 그 제조방법 |
| CN112040984A (zh) * | 2018-02-07 | 2020-12-04 | 斯码瓦有限公司 | 药物制剂、制备药物制剂的方法和包含其的药物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
| GB9401090D0 (en) | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
| GB9514465D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
| GB9423911D0 (en) * | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
| GB9511220D0 (en) * | 1995-06-02 | 1995-07-26 | Glaxo Group Ltd | Solid dispersions |
| GB9514473D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
| GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
| EE9800390A (et) | 1996-05-10 | 1999-06-15 | Icos Corporation | Karboliini derivaadid |
| CA2288910C (en) * | 1997-04-25 | 2003-06-24 | Pfizer Inc. | Pyrazolopyrimidinones for sexual dysfunction |
| AU4068599A (en) * | 1998-05-20 | 1999-12-06 | Schering Corporation | Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction |
| WO2000015639A1 (en) | 1998-09-16 | 2000-03-23 | Icos Corporation | Carboline derivatives as cgmp phosphodiesterase inhibitors |
| EP1120120A4 (en) * | 1998-10-05 | 2009-04-29 | Eisai R&D Man Co Ltd | TABLETS DISSOLVING DIRECTLY IN MOUTH |
| AU3724400A (en) * | 1999-03-08 | 2000-09-28 | Merck & Co., Inc. | Methods and compositions for treating erectile dysfunction |
| US6613768B1 (en) * | 1999-04-30 | 2003-09-02 | Lilly Icos Llc | Treatment of female arousal disorder |
| US6451807B1 (en) * | 1999-04-30 | 2002-09-17 | Lilly Icos, Llc. | Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor |
-
2000
- 2000-04-25 IL IL13581700A patent/IL135817A0/xx unknown
- 2000-04-25 NO NO20002097A patent/NO20002097L/no not_active Application Discontinuation
- 2000-04-25 ES ES200001055A patent/ES2187234A1/es not_active Withdrawn
- 2000-04-25 SV SV2000000055A patent/SV2002000055A/es not_active Application Discontinuation
- 2000-04-25 HU HU0001632A patent/HUP0001632A3/hu unknown
- 2000-04-25 MX MXPA00003997A patent/MXPA00003997A/es unknown
- 2000-04-26 IT IT2000MI000922A patent/ITMI20000922A1/it unknown
- 2000-04-26 LV LVP-00-56A patent/LV12560B/en unknown
- 2000-04-26 HR HR20000243A patent/HRP20000243A2/hr not_active Application Discontinuation
- 2000-04-26 ID IDP20000331D patent/ID25704A/id unknown
- 2000-04-26 AU AU44908/00A patent/AU769946C/en not_active Expired
- 2000-04-26 NL NL1015027A patent/NL1015027C2/nl not_active IP Right Cessation
- 2000-04-26 EP EP00926367.4A patent/EP1173181B3/en not_active Expired - Lifetime
- 2000-04-26 TR TR2000/01132A patent/TR200001132A3/tr unknown
- 2000-04-26 BR BR0003046-5A patent/BR0003046A/pt not_active IP Right Cessation
- 2000-04-26 CH CH00926367.4T patent/CH1173181H1/de unknown
- 2000-04-26 SI SI200000107A patent/SI20361A/sl not_active IP Right Cessation
- 2000-04-26 CZ CZ20013879A patent/CZ296534B6/cs not_active IP Right Cessation
- 2000-04-26 AT AT00926367T patent/ATE251908T1/de active
- 2000-04-26 PL PL00339897A patent/PL339897A1/xx not_active Application Discontinuation
- 2000-04-26 JP JP2000126472A patent/JP2000336043A/ja active Pending
- 2000-04-26 IE IE20000315A patent/IE20000315A1/en not_active IP Right Cessation
- 2000-04-26 BE BE2000/0295A patent/BE1012957A5/fr not_active IP Right Cessation
- 2000-04-26 DK DK200000677A patent/DK200000677A/da not_active Application Discontinuation
- 2000-04-26 EP EP03023276A patent/EP1415652A3/en not_active Withdrawn
- 2000-04-26 FI FI20000976A patent/FI20000976A/fi not_active IP Right Cessation
- 2000-04-26 LT LT2000035A patent/LT4758B/lt not_active IP Right Cessation
- 2000-04-26 DE DE60005940.5T patent/DE60005940T3/de not_active Expired - Lifetime
- 2000-04-26 PT PT00926367T patent/PT1173181E/pt unknown
- 2000-04-26 DZ DZ003171A patent/DZ3171A1/xx active
- 2000-04-26 MX MXPA01010837A patent/MXPA01010837A/es active IP Right Grant
- 2000-04-26 DE DE20007861U patent/DE20007861U1/de not_active Expired - Lifetime
- 2000-04-26 SI SI200030225T patent/SI1173181T1/xx unknown
- 2000-04-26 DE DE10021266A patent/DE10021266A1/de not_active Withdrawn
- 2000-04-26 CA CA002307101A patent/CA2307101C/en not_active Expired - Fee Related
- 2000-04-26 ZA ZA200002058A patent/ZA200002058B/xx unknown
- 2000-04-26 JP JP2000614984A patent/JP4975214B2/ja not_active Expired - Lifetime
- 2000-04-26 DK DK00926367T patent/DK1173181T6/en active
- 2000-04-26 CH CH00819/00A patent/CH692478A5/de not_active IP Right Cessation
- 2000-04-26 GR GR20000100153A patent/GR1003575B/el unknown
- 2000-04-26 AU AU30129/00A patent/AU3012900A/en not_active Abandoned
- 2000-04-26 PT PT102457A patent/PT102457A/pt unknown
- 2000-04-26 CA CA002371684A patent/CA2371684C/en not_active Expired - Lifetime
- 2000-04-26 ES ES00926367.4T patent/ES2208317T7/es active Active
- 2000-04-26 SK SK1563-2001A patent/SK285415B6/sk not_active IP Right Cessation
- 2000-04-26 LU LU90569A patent/LU90569B1/fr active
- 2000-04-26 SE SE0001518A patent/SE0001518L/xx not_active Application Discontinuation
- 2000-04-26 EA EA200000355A patent/EA200000355A3/ru unknown
- 2000-04-26 KR KR1020017013747A patent/KR100577057B1/ko active IP Right Review Request
- 2000-04-26 HU HU0200912A patent/HU230369B1/hu not_active IP Right Cessation
- 2000-04-26 CO CO00029997A patent/CO5170493A1/es not_active Application Discontinuation
- 2000-04-26 NZ NZ514882A patent/NZ514882A/en not_active IP Right Cessation
- 2000-04-26 EA EA200101008A patent/EA005416B1/ru not_active IP Right Cessation
- 2000-04-26 KR KR1020000022108A patent/KR20010020779A/ko not_active Application Discontinuation
- 2000-04-26 CN CN00106987XA patent/CN1292264A/zh active Pending
- 2000-04-26 NZ NZ504163A patent/NZ504163A/en unknown
- 2000-04-26 SG SG200002287A patent/SG98384A1/en unknown
- 2000-04-26 BR BR0010181-8A patent/BR0010181A/pt not_active Application Discontinuation
- 2000-04-26 PE PE2000000388A patent/PE20010071A1/es not_active Application Discontinuation
- 2000-04-26 FR FR0005296A patent/FR2795646B1/fr not_active Expired - Fee Related
- 2000-04-26 UA UA2001118182A patent/UA72248C2/uk unknown
- 2000-04-26 PL PL352629A patent/PL197813B1/pl unknown
- 2000-04-26 CN CNB008097771A patent/CN1196487C/zh not_active Expired - Lifetime
- 2000-04-26 IL IL14609800A patent/IL146098A0/xx unknown
- 2000-04-26 GB GB0010199A patent/GB2351663A/en not_active Withdrawn
- 2000-04-26 WO PCT/US2000/011129 patent/WO2000066099A2/en active IP Right Grant
-
2001
- 2001-10-22 IL IL146098A patent/IL146098A/en not_active IP Right Cessation
- 2001-10-23 HR HR20010778A patent/HRP20010778B1/xx not_active IP Right Cessation
- 2001-10-29 ZA ZA200108900A patent/ZA200108900B/xx unknown
- 2001-10-29 NO NO20015275A patent/NO322013B3/no not_active IP Right Cessation
-
2002
- 2002-02-26 HK HK02101474.1A patent/HK1041204B/zh not_active IP Right Cessation
-
2004
- 2004-05-12 AU AU2004201988A patent/AU2004201988A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5170493A1 (es) | Articulos de fabricacion | |
| WO2001080860A3 (en) | Daily treatment for erectile dysfunction using a pde5 inhibitor | |
| ECSP003429A (es) | Productos de elaboracion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |